From neurological problems to hearing loss and infertility, survivors of medulloblastoma, an aggressive form of brain cancer, are left with severe physical and cognitive impairments and have an overall mortality rate 21 times ...
Mar 28, 2023
0
4
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens.
Dec 30, 2022
0
57
Two treatment regimens for multidrug-resistant tuberculosis (TB), containing the first new drug to have been discovered for the disease in 40 years, are more effective than a previously recommended treatment, according to ...
Nov 10, 2022
0
7
A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children's Oncology Group (COG) and led ...
Nov 3, 2022
0
35
When methadone is given to people who want to break their opioid addiction, federal law requires those patients to initially consume their daily dose in view of opioid treatment program staff. This requirement exists in part ...
Oct 14, 2022
0
5
Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast cancer cells regulate their own metastases, fuel dissemination from the original tumor site, and determine routes to invade distant ...
Sep 20, 2022
0
8
Two new treatments for Crohn's disease showed roughly equal performance in a clinical trial, according to findings published in The Lancet.
Jul 18, 2022
1
78
Experiencing higher rates of certain cancers than non-Hispanic whites, many Native Americans have to travel especially large distances to access radiation therapy, according to a study led by Washington State University researchers.
Jun 13, 2022
0
3
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieved excellent outcomes, ...
Apr 8, 2021
0
11
Among patients with lymphoma admitted to the hospital for severe COVID-19, those treated with B-cell-depleting therapies within the previous 12 months had an increased risk of prolonged hospital stay and death, according ...
Feb 4, 2021
0
3
